← Open Payments lookup

JAMES MATTHEWS: Open Payments

NPI 1669258711 · WASHINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,214 in 75 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $538 · 2025 $1,214

Food & beverage: $1,214
CompanyPaymentsAmount
ABBVIE INC.22$227
Alkermes, Inc.10$197
E.R. Squibb & Sons, L.L.C.10$170
Teva Pharmaceuticals USA, Inc.10$154
Neurocrine BioSciences, Inc.8$143
Janssen Pharmaceuticals, Inc5$121
Otsuka America Pharmaceutical, Inc.4$94
Takeda Pharmaceuticals U.S.A., Inc.4$80
Supernus Pharmaceuticals, Inc.1$15
Vanda Pharmaceuticals Inc.1$14

Products named: VRAYLAR, ARISTADA, COBENFY, INGREZZA, INVEGA SUSTENNA, AUSTEDO XR, TRINTELLIX, REXULTI.

Industry payments across NC — which companies pay providers there.